Shengqiang Xu

机构：National Supercomputing Center in Shenzhen

发表论文 15 篇 · 总被引 222 次 · h-index 6

代表论文

• Multicenter phase II trial of Camrelizumab combined with Apatinib and Eribulin in heavily pretreated patients with advanced triple-negative breast cancer (2022 · Nature Communications · 被引 104)
• Ribosomal protein RPL41 induces rapid degradation of ATF4, a transcription factor critical for tumour cell survival in stress (2011 · The Journal of Pathology · 被引 44)
• RPL41, a Small Ribosomal Peptide Deregulated in Tumors, Is Essential for Mitosis and Centrosome Integrity (2010 · Neoplasia · 被引 44)
• AIF Downregulation and Its Interaction with STK3 in Renal Cell Carcinoma (2014 · PLoS ONE · 被引 13)
• A Taylor expansion approach for solving partial differential equations with random Neumann boundary conditions (2011 · Applied Mathematics and Computation · 被引 8)
• Expression profile of mouse Mterfd2, a novel component of the mitochondrial transcription termination factor (MTERF) family (2011 · Genes & Genetic Systems · 被引 6)